The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh (RESEDAE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04282473
Recruitment Status : Unknown
Verified February 2022 by Centre Hospitalier Universitaire de Nīmes.
Recruitment status was:  Recruiting
First Posted : February 24, 2020
Last Update Posted : September 28, 2022
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nīmes

Tracking Information
First Submitted Date February 21, 2020
First Posted Date February 24, 2020
Last Update Posted Date September 28, 2022
Actual Study Start Date May 24, 2022
Estimated Primary Completion Date May 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: February 21, 2020)
  • Rate of parastomal hernia between groups [ Time Frame: 5 years after colostomy formation ]
    Percentage patients with parastomal hernia taken from patient medical records
  • Date of parastomal hernia [ Time Frame: 5 years after colostomy formation ]
    Date of parastomal hernia taken from patient records
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: February 21, 2020)
  • Protrusion around the stoma [ Time Frame: 5 years after colostomy formation ]
    Yes/no
  • Patient reported pain [ Time Frame: 5 years after colostomy formation ]
    Yes/no
  • Occlusion [ Time Frame: 5 years after colostomy formation ]
    Yes/no
  • Incarceration [ Time Frame: 5 years after colostomy formation ]
    Yes/no
  • Patient reported quality of life [ Time Frame: 5 years after colostomy formation ]
    Stoma-QoL questionnaire - a 20-item questionnaire on a four-point Likert scale with total score ranging from 0 (worst score) to 100 (best score)
  • Pain at colostomy site [ Time Frame: 5 years after colostomy formation ]
    0-100 scale (no pain to intolerable pain)
  • Discomfort [ Time Frame: 5 years after colostomy formation ]
    0-100 scale (very uncomfortable to very comfortable)
  • Patient reported satisfaction [ Time Frame: 5 years after colostomy formation ]
    0-100 scale (not at all satisfied to very satisfied)
  • Number of specialist and general consultations attended by patients between groups [ Time Frame: 5 years after colostomy formation ]
    number of consultations
  • Number of medications taken in each group [ Time Frame: 5 years after colostomy formation ]
    Number of medications taken
  • Other associated treatment received by patients in each group [ Time Frame: 5 years after colostomy formation ]
    number of treatments received
  • Rehabilitation sessions undergone by patients in each group [ Time Frame: 5 years after colostomy formation ]
    number of rehabilitation sessions
  • Sick leave taken by patients in each group [ Time Frame: 5 years after colostomy formation ]
    Number of days
  • Cost of patients care [ Time Frame: 5 years after colostomy formation ]
    Euros
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh
Official Title Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh: Material-epidemiology Study
Brief Summary This study is a follow-up of the GRECCAR 07 cohort (NCT01380860). Patients will be evaluated 5 years following terminal colostomy to observe patient long-term patient outcomes from colostomy with and without mesh placement.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population The study population consists of patients included in the GRECCAR 07 cohort.
Condition
  • Colostomy Stoma
  • Parastomal Hernia
Intervention Not Provided
Study Groups/Cohorts
  • with mesh
    Placement of lightweight (<50g/m2) monofilament mesh during colostomy formation
  • no mesh
    colostomy without mesh placement
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: February 21, 2020)
134
Original Estimated Enrollment Same as current
Estimated Study Completion Date May 2024
Estimated Primary Completion Date May 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • The patient must be affiliated with a health insurance programme
  • Patient was included in the GRECCAR 07 cohort (PHRC National 2011; N° RCB: 2011-A01572-39 - ClinicalTrials.gov ID: NCT01380860)
  • Patient received colostomy 5 years ago

Exclusion Criteria:

  • The subject is participating in another category I interventional study, or is in a period of exclusion determined by a previous study
  • The subject signals opposition to participating in the study
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breastfeeding
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT04282473
Other Study ID Numbers NIMAO/2018-02/MP-01
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Current Responsible Party Centre Hospitalier Universitaire de Nīmes
Original Responsible Party Same as current
Current Study Sponsor Centre Hospitalier Universitaire de Nīmes
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators
Principal Investigator: Michel Prudhomme, MD CHU Nimes
PRS Account Centre Hospitalier Universitaire de Nīmes
Verification Date February 2022